New research center focuses on origins of prenatal and neonatal disease
Children’s National Hospital researchers will develop new diagnostic tools and precision medicine for unborn children, babies and young children at the hospital’s newly established Center for Prenatal, Neonatal & Maternal Health Research.
The investment comes as research continues to show the importance of high-quality, evidence-based care at this crucial stage of pediatric development, especially for underserved families. The center is the sixth organization to join the Children’s National Research Institute.
What we hope to discover
“We know that many chronic diseases that crop up during adulthood have their footprint in the womb,” said center Director Catherine Limperopoulos, Ph.D. “While this concept has been around for years, our new center will provide a unique opportunity to study such research questions as the role of prenatal stressors on long-term outcomes. And we’ll be able to provide interventions earlier, improving mothers’ outcomes sooner. This benefits the mom, the fetus, the child and has implications for the next generation.”
Limperopoulos’s research will continue the hospital’s longstanding investment in improving the understanding, prevention and treatment of childhood diseases. The center will foster collaborations throughout the hospital by teaming with experts in neuroscience, oncology, genetics and other disciplines that are vital for safeguarding the health of mothers and their babies, even before they’re born.
The big picture
Limperopoulos will also continue to serve as the director of the Children’s National Developing Brain Institute, which focuses on the brain in utero, after birth and throughout preschool. Her research is paving the way toward understanding how maternal stress impacts fetal brain development and helping to advance perinatal mental health while addressing racial disparities in access to care. The center will also partner with clinical leaders throughout Children’s National and community partners to expand existing efforts, such as the DC Mother-Baby Wellness Initiative, an innovative program that Limperopoulos leads.
“The care of mothers and their young children will change dramatically in the next decade, and the breadth of our research has the power to lead the way in harnessing medical advancements to nurture healthier families,” Limperopoulos said. “Imagine a day when we can identify in utero a biomarker for a disorder such as sickle cell disease and prevent the disease from taking hold with a novel therapy. This is the vision for the groundbreaking research that will happen at the new center.”